![]() |
Trials |
Safety, pharmacokinetics and efficacy of AXP107-11 in patients with standard gemcitabine (Gemzar®) treatment in patients with locally advanced or metastatic, unresectable, adenocarcinoma of the pancreas, stage III-IV.Cancer type: Pancreatic cancer Phase: I/II Principal Investigator: Frödin Jan-Erik Country: SE Keywords: Sweden, AXP107-11, pancreatic cancer Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01182246?term=NCT01182246&rank=1 |